Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia

This cohort study describes patterns of development, management strategies, and long-term vascular consequences of hypertension associated with ibrutinib in the non–clinical trial setting.

Detalles Bibliográficos
Autores principales: Roeker, Lindsey E., Sarraf Yazdy, Maryam, Rhodes, Joanna, Goodfriend, Julie, Narkhede, Mayur, Carver, Joseph, Mato, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902749/
https://www.ncbi.nlm.nih.gov/pubmed/31790561
http://dx.doi.org/10.1001/jamanetworkopen.2019.16326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902749/
https://www.ncbi.nlm.nih.gov/pubmed/31790561
http://dx.doi.org/10.1001/jamanetworkopen.2019.16326

Ejemplares similares